Martine Paula van Gool
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Martine Paula van Gool has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
H.A. Schols
5 shared publicationsH. Gruppen
4 shared publicationsA.P. Sinitsyn
2 shared publicationsAnna Ebringerová
2 shared publicationsG. Szakacs
2 shared publicationsG.C.J. van Muiswinkel
2 shared publications
Latest Publications
- 24 August 2024
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 107 (6) , 971-978
Determination of Taurine in Infant Formula and Adult/Pediatric Nutritionals by Ultra High-Performance Liquid Chromatography with Multiple Reaction Monitoring-Mass Spectrometry: Single-Laboratory Validation, First Action 2022.08
Taurine (2-aminoethanesulfonic acid) is an essential β-amino acid which is one of the most abundant intracellular amino acid-like components in humans. The level of free taurine in human milk is higher than in bovine milk. Since taurine is considered important for the development of a newborn, fortification of taurine to infant nutrition is common. This publication describes a rapid method for the determination of taurine in infant formula and adult/pediatric nutritionals. This publication demonstrates the suitability and applicability of the method to determine taurine content in infant formula and adult/pediatric nutritionals. Test portions are deproteinized by acid in aqueous environment prior to analysis. The level of taurine is analyzed by Hydrophilic Interaction Chromatography (HILIC) coupled with Multiple Reaction Monitoring Mass Spectrometry (MRM-MS). Quantitation is accomplished using a stable isotope labeled internal standard (SILS) for taurine. The accuracy of the method was validated using standard reference materials and spike recovery studies. The average recoveries ranged between 92–105%. The repeatability and intermediate precision were in the range of 0.7–4.6% (RSDr) and 1.3–6.7% (RSDiR). The limit of quantification was below the requirement of 0.5 mg/100 g. The single laboratory validation (SLV) of the method for determination of taurine content in infant formula and adult/pediatric nutritionals demonstrates that it meets the requirements as per AOAC SMPR 2014.013. A fast method to selectively determine the content of taurine in infant formula and adult/pediatric nutritionals was evaluated and found to be fit for purpose for routine product compliance testing. Based on the results of this SLV, the method was approved by the AOAC Stakeholder Program on Infant Formula and Adult Nutritionals (SPIFAN) Expert Review Panel for SPIFAN Nutrient Methods for Official Methods First Action status.
- 24 August 2024
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 107 (6) , 971-978
Determination of Taurine in Infant Formula and Adult/Pediatric Nutritionals by Ultra High-Performance Liquid Chromatography with Multiple Reaction Monitoring-Mass Spectrometry: Single-Laboratory Validation, First Action 2022.08
Taurine (2-aminoethanesulfonic acid) is an essential β-amino acid which is one of the most abundant intracellular amino acid-like components in humans. The level of free taurine in human milk is higher than in bovine milk. Since taurine is considered important for the development of a newborn, fortification of taurine to infant nutrition is common. This publication describes a rapid method for the determination of taurine in infant formula and adult/pediatric nutritionals. This publication demonstrates the suitability and applicability of the method to determine taurine content in infant formula and adult/pediatric nutritionals. Test portions are deproteinized by acid in aqueous environment prior to analysis. The level of taurine is analyzed by Hydrophilic Interaction Chromatography (HILIC) coupled with Multiple Reaction Monitoring Mass Spectrometry (MRM-MS). Quantitation is accomplished using a stable isotope labeled internal standard (SILS) for taurine. The accuracy of the method was validated using standard reference materials and spike recovery studies. The average recoveries ranged between 92–105%. The repeatability and intermediate precision were in the range of 0.7–4.6% (RSDr) and 1.3–6.7% (RSDiR). The limit of quantification was below the requirement of 0.5 mg/100 g. The single laboratory validation (SLV) of the method for determination of taurine content in infant formula and adult/pediatric nutritionals demonstrates that it meets the requirements as per AOAC SMPR 2014.013. A fast method to selectively determine the content of taurine in infant formula and adult/pediatric nutritionals was evaluated and found to be fit for purpose for routine product compliance testing. Based on the results of this SLV, the method was approved by the AOAC Stakeholder Program on Infant Formula and Adult Nutritionals (SPIFAN) Expert Review Panel for SPIFAN Nutrient Methods for Official Methods First Action status.
- 23 May 2022
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 105 (5) , 1360-1366
Assessment of Regulatory Compliance Testing for Vitamin D in Infant Formula—Impact of Delegated Regulation (EU) 2019/828
Since the publication of Standard Method Performance Requirements (SMPR®) for vitamin D in infant formula (SMPR 2011.004) by AOAC INTERNATIONAL, revised vitamin D limits have been recommended by the European Food Safety Authority (EFSA) for infant formula and adopted in Commission Delegated Regulation (EU) 2019/828. The vitamin D range introduced, 2–2.5 μg/100 kcal, is significantly narrower than previous limits specified by Codex Standard 72–1981 and requires lower method reproducibility metrics to adequately assess regulatory compliance. The narrower limits for vitamin D present a significant challenge for current-generation reference analytical methods that comply with SMPR 2011.004. We evaluate the impact of Delegated Regulation (EU) 2019/828 on the demonstrated performance of AOAC 2016.05/ISO 20636:2018 to assess the likelihood that vitamin D results produced by the method would be found outside the EU limits when testing infant formula that is compliant as manufactured. AOAC 2016.05/ISO 20636:2018, specifically data generated during multi-laboratory study, was used as a basis for statistical evaluation of the impact of the narrower EU vitamin D limits. The review of AOAC 2016.05/ISO 20636:2018 method performance against the vitamin D regulatory range introduced in (EU) 2019/828 indicates methods capable of performing in alignment with SMPR 2011.004 are likely to produce results that fail to meet EU requirements. Our assessment illustrates the high probability that a well-manufactured product with vitamin D levels within the EU regulatory range would fail to meet the regulatory requirements due to analytical method variability when tested using fit-for-purpose methods. Further, required method performance cannot be expected with the future development of new methods. To avoid this, consideration should be given to aligning proposed regulatory limits with method performance metrics of current-generation compendial methods. Current, state-of-the-art methods cannot consistently verify infant formula product compliance for vitamin D in accordance with (EU) 2019/828.
- 23 May 2022
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 105 (5) , 1360-1366
Assessment of Regulatory Compliance Testing for Vitamin D in Infant Formula—Impact of Delegated Regulation (EU) 2019/828
Since the publication of Standard Method Performance Requirements (SMPR®) for vitamin D in infant formula (SMPR 2011.004) by AOAC INTERNATIONAL, revised vitamin D limits have been recommended by the European Food Safety Authority (EFSA) for infant formula and adopted in Commission Delegated Regulation (EU) 2019/828. The vitamin D range introduced, 2–2.5 μg/100 kcal, is significantly narrower than previous limits specified by Codex Standard 72–1981 and requires lower method reproducibility metrics to adequately assess regulatory compliance. The narrower limits for vitamin D present a significant challenge for current-generation reference analytical methods that comply with SMPR 2011.004. We evaluate the impact of Delegated Regulation (EU) 2019/828 on the demonstrated performance of AOAC 2016.05/ISO 20636:2018 to assess the likelihood that vitamin D results produced by the method would be found outside the EU limits when testing infant formula that is compliant as manufactured. AOAC 2016.05/ISO 20636:2018, specifically data generated during multi-laboratory study, was used as a basis for statistical evaluation of the impact of the narrower EU vitamin D limits. The review of AOAC 2016.05/ISO 20636:2018 method performance against the vitamin D regulatory range introduced in (EU) 2019/828 indicates methods capable of performing in alignment with SMPR 2011.004 are likely to produce results that fail to meet EU requirements. Our assessment illustrates the high probability that a well-manufactured product with vitamin D levels within the EU regulatory range would fail to meet the regulatory requirements due to analytical method variability when tested using fit-for-purpose methods. Further, required method performance cannot be expected with the future development of new methods. To avoid this, consideration should be given to aligning proposed regulatory limits with method performance metrics of current-generation compendial methods. Current, state-of-the-art methods cannot consistently verify infant formula product compliance for vitamin D in accordance with (EU) 2019/828.
- Open Access
- 2 February 2022
- Published by Elsevier in International Dairy Journal
- Vol. 129
Identifying glycation hot-spots in bovine milk proteins during production and storage of skim milk powder
- 2 February 2022
- Published by Elsevier in International Dairy Journal
- Vol. 129
Open AccessIdentifying glycation hot-spots in bovine milk proteins during production and storage of skim milk powder
- Open Access
- 4 December 2019
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 11 (1) , 358-369
Lysine blockage of milk proteins in infant formula impairs overall protein digestibility and peptide release
During heat processing of milk and dairy products, for example infant formula, the Maillard reaction occurs. In vitro and animal studies suggest that Maillard reaction induced lysine blockage impairs protein digestibility. Most studies that investigate the effect of glycation on protein digestion use a mixture of isolated milk protein with reducing sugars. In this study, infant formulas with 6.5%, 8.4%, 11.2%, 14.8%, 20.8%, and 44.5% of blocked lysine (BL) were digested in an in vitro infant digestion model and tested for protein hydrolysis and peptide release. OPA (o-phthalaldehyde) assay was used to assess the degree of protein hydrolysis. SDS-PAGE was conducted to monitor the hydrolysis of specific proteins. Peptides formed after gastric and intestinal digestion were identified by LC/MS. Protein hydrolysis of the 6.5% BL sample was significantly higher after 10 minutes of intestinal digestion compared to all other samples. Most differences were observed after intestinal digestion. A significant change in peptide patterns was observed for the 45% BL sample resulting in a relatively higher number of peptides with more than 14 amino acids. Mainly casein-derived peptides were affected. Overall, the average peptide length was significantly increased for the 44.5% BL glycated product (on average 10.2 amino acids for 6–21% BL vs. 11.4 amino acids for 45% BL; p < 0.001). In conclusion, glycation of milk proteins in an infant formula product can impair overall protein digestibility. These findings emphasize the importance of mild processing and having low BL levels in infant formula to ensure optimal digestion of proteins.
- 4 December 2019
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 11 (1) , 358-369
Open AccessLysine blockage of milk proteins in infant formula impairs overall protein digestibility and peptide release
During heat processing of milk and dairy products, for example infant formula, the Maillard reaction occurs. In vitro and animal studies suggest that Maillard reaction induced lysine blockage impairs protein digestibility. Most studies that investigate the effect of glycation on protein digestion use a mixture of isolated milk protein with reducing sugars. In this study, infant formulas with 6.5%, 8.4%, 11.2%, 14.8%, 20.8%, and 44.5% of blocked lysine (BL) were digested in an in vitro infant digestion model and tested for protein hydrolysis and peptide release. OPA (o-phthalaldehyde) assay was used to assess the degree of protein hydrolysis. SDS-PAGE was conducted to monitor the hydrolysis of specific proteins. Peptides formed after gastric and intestinal digestion were identified by LC/MS. Protein hydrolysis of the 6.5% BL sample was significantly higher after 10 minutes of intestinal digestion compared to all other samples. Most differences were observed after intestinal digestion. A significant change in peptide patterns was observed for the 45% BL sample resulting in a relatively higher number of peptides with more than 14 amino acids. Mainly casein-derived peptides were affected. Overall, the average peptide length was significantly increased for the 44.5% BL glycated product (on average 10.2 amino acids for 6–21% BL vs. 11.4 amino acids for 45% BL; p < 0.001). In conclusion, glycation of milk proteins in an infant formula product can impair overall protein digestibility. These findings emphasize the importance of mild processing and having low BL levels in infant formula to ensure optimal digestion of proteins.
- Open Access
- 2 November 2018
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 62 (23) , e1800716
Identification of a TLR2 Inhibiting Wheat Hydrolysate
Scope: Wheat hydrolysates are used in medical nutrition to provide undernourished patients a readily digestible protein source, for instance to recover from chemotherapy‐induced intestinal mucosal inflammation. Since many hydrolysates of different sources can modulate the immune system, likely via Toll‐like receptors (TLRs), it is hypothesized that also wheat hydrolysates might interact with TLR signaling, which could be a way to prevent intestinal inflammation and damage.Methods and results: The capacity of three wheat hydrolysates to modulate immunity by interfering with TLR signaling is determined. All wheat hydrolysates have TLR modulating effects but only one has strong TLR2 inhibiting effects, attenuating both TLR2/1 and TLR2/6 signaling in a reporter cell system. This is likely induced by direct TLR2‐ectodomain binding, as confirmed by ELISA. Furthermore, this TLR2 blocking hydrolysate reduces IL‐6 production in human dendritic cells. Application of reversed‐phase–ultra HPLC combined with MS reveals that the presence of peptide WQIPEQSR is associated with the observed TLR2 inhibiting capacity.Conclusion: The study demonstrates TLR2‐inhibiting capacities of a wheat hydrolysate. The findings provide a good start for further research to investigate whether this hydrolysate might contribute to the management of intestinal mucosal inflammation in cancer patients receiving chemotherapy.
- 2 November 2018
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 62 (23) , e1800716
Open AccessIdentification of a TLR2 Inhibiting Wheat Hydrolysate
Scope: Wheat hydrolysates are used in medical nutrition to provide undernourished patients a readily digestible protein source, for instance to recover from chemotherapy‐induced intestinal mucosal inflammation. Since many hydrolysates of different sources can modulate the immune system, likely via Toll‐like receptors (TLRs), it is hypothesized that also wheat hydrolysates might interact with TLR signaling, which could be a way to prevent intestinal inflammation and damage.Methods and results: The capacity of three wheat hydrolysates to modulate immunity by interfering with TLR signaling is determined. All wheat hydrolysates have TLR modulating effects but only one has strong TLR2 inhibiting effects, attenuating both TLR2/1 and TLR2/6 signaling in a reporter cell system. This is likely induced by direct TLR2‐ectodomain binding, as confirmed by ELISA. Furthermore, this TLR2 blocking hydrolysate reduces IL‐6 production in human dendritic cells. Application of reversed‐phase–ultra HPLC combined with MS reveals that the presence of peptide WQIPEQSR is associated with the observed TLR2 inhibiting capacity.Conclusion: The study demonstrates TLR2‐inhibiting capacities of a wheat hydrolysate. The findings provide a good start for further research to investigate whether this hydrolysate might contribute to the management of intestinal mucosal inflammation in cancer patients receiving chemotherapy.
- 1 July 2018
- Published by Oxford University Press (OUP)
- Vol. 101 (4) , 1270-1271
Standard Method Performance Requirements (SMPRs®) 2014.003: Revised: Determinional of GOS in Infant Formula and Adult/Pediatric Nutritional Formula
- 1 July 2018
- Published by Oxford University Press (OUP)
- Vol. 101 (4) , 1270-1271
Standard Method Performance Requirements (SMPRs®) 2014.003: Revised: Determinional of GOS in Infant Formula and Adult/Pediatric Nutritional Formula
- 1 December 2013
- Published by Elsevier in Journal of Biotechnology
- Vol. 168 (4) , 684-692
Distinct roles of carbohydrate esterase family CE16 acetyl esterases and polymer-acting acetyl xylan esterases in xylan deacetylation
- 1 December 2013
- Published by Elsevier in Journal of Biotechnology
- Vol. 168 (4) , 684-692
Distinct roles of carbohydrate esterase family CE16 acetyl esterases and polymer-acting acetyl xylan esterases in xylan deacetylation
- 1 June 2013
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 53 (1) , 25-32
Two novel GH11 endo-xylanases from Myceliophthora thermophila C1 act differently toward soluble and insoluble xylans
- 1 June 2013
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 53 (1) , 25-32
Two novel GH11 endo-xylanases from Myceliophthora thermophila C1 act differently toward soluble and insoluble xylans
- 7 December 2012
- Published by Springer Nature in BioEnergy Research
- Vol. 6 (2) , 631-643
Diversity in Production of Xylan-Degrading Enzymes Among Species Belonging to the Trichoderma Section Longibrachiatum
- 7 December 2012
- Published by Springer Nature in BioEnergy Research
- Vol. 6 (2) , 631-643
Diversity in Production of Xylan-Degrading Enzymes Among Species Belonging to the Trichoderma Section Longibrachiatum